
View larger version (79K):
[in a new window]
|
Fig. 8. Injection of AS-Hro-eve MO into N lineage perturbs gangliogenesis and neuronal differentiation (anterior is upwards). (A-C) Fluorescence images of the dissected germinal plate from a stage 10 embryo, in which one N teloblast had been co-injected with MM-Hro-eve MO and FDA (green), and the other with AS-Hro-eve MO and RDA (red) at early stage 7; nuclei are counterstained with Hoechst 33258 (blue). (B,C) Close-up views of the sections indicated by boxes in the anterior and posterior regions of A, respectively. On the control side (left), development of the N lineage is normal; peripheral nz neurons (derived from the nf blast cell clones) are present in anterior segments (arrows in B), and anterior and posterior lobes of cells (derived from ns and nf, respectively) that form the bulk of the ganglionic primordia are visible in posterior segments (C). On the experimental (right) side, the overall size and regularity of the n-derived clones are reduced and nz neurons are largely absent. (D) Fluorescence image of a preparation as in A, but processed for Hro-eve transcripts at stage 10. Two anterior ganglia, containing n blast cell clones produced prior to the injections, show bilaterally paired posterior spots of cells expressing Hro-eve (double arrows). On the control (left) side, these spots continue with segmental periodicity for a total of 14 segments (horizontal arrows; the spot in the third segment is out of focus); in the three youngest segments, the transient, anterior spots of Hro-eve expression are also visible on the control side (e.g. yoked arrowheads and arrows). On the experimental side, spots of Hro-eve expression are frequently missing, out of register, or misplaced medially with respect to those on the control side (slanted arrows). (E) Brightfield (Nomarski optics) showing approx. five ganglia from another embryo, treated as in D. Note the abnormal ganglion morphology and ectopically positioned Hro-eve spots (slanted arrows) on the experimental (right) side relative to the control side (horizontal arrows). (F) Combined bright-field and fluorescence image, showing the first five midbody ganglia (M1-M5) of an embryo injected as in A, but grown to stage 11 and processed for serotonergic neurons, which normally arise in bilateral pairs from the N teloblast lineages. No serotonergic neurons arose from the N teloblast injected with AS-Hro-eve MO and there is a gap (bracket) in the RDA-labeled lineage where N-derived neurons are missing. In M1-M5 of the control side (left), previously described serotonergic neurons (Stuart et al., 1987 ) can be identified, including the Retzius cells (Rz) and a pair of dorsolateral and ventrolateral cells (dl/vl). Ganglia M1-M3 also contain a smaller anteromedial (am) neuron. A fourth, posteromedial neuron was not detected because it develops later. (G) Digital montage fluorescence image combining several focal planes of five segments from a stage 11 embryo, in which an O teloblast had been injected with RDA and MM-Hro-eve MO at stage 7; in each segment, the O lineage generates distinct subsets of ganglionic neurons (AD, PV, CR), epidermal cells (e), plus peripheral neurons (most of which are not visible in this figure). (H) Equivalent view of a sibling embryo to that shown in G, that had been injected with AS-Hro-eve MO; clusters of undifferentiated cells are present over the ganglion (g) and in the periphery (p). Scale bar: 200 µm in A; 50 µm in B,C,F; 150 µm in D; 100 µm in E,G,H.
|